CG Inbites, Merger by Absorption of Makaon Biotherapeutics

CG Inbites announced on the 11th that it will absorb and merge with Makaon Biotherapeutics.

The purpose of the merger is to increase management efficiency and maximize synergy through the merger, and the form of the merger is a small-scale merger. Makaon Biotherapeutics' main business is pharmaceutical research and development.